chasfh

I was wrong. I’m already done with them. 🤢🤮

It’s July 1 so it looks like there’s a whole new batch of streaming commercials I’m seeing for the first time and will be tearing my hair out every time they come on by August.

And then there’s Jonathan Schoop! I have never seen such a best-of the-year play followed by such a worst-of-the-year play.

Holy Toledo, Javy’s still got it at short!

The other thing is that Eduardo’s underlying numbers are flashing outlier warning lights. Sure, his ERA- is 51, but he’s also getting a little lucky on HR/FB, BABIP, and LOB. That’s why his RA9-WAR is 2.6 but his regular WAR is 1.7–still pretty good, but not quite All-Star level. The one real good thing Eduardo is doing is bringing his walk rate down a couple ticks, better than his 2021 number. Beyond that, his topline numbers are stellar and someone is going to give him the combination to the safe next year. I just hope it’s not us.

I thought given where he was and his likely rebound even to the low projection of 1.1, he was a low-risk sign. I also thought it was defensible to keep Willi. I would not have said the same thing about Schoop.

He has been protected from the law by the human armor that is MAGA nation, which hangs on his every word like it is the gospel of Jesus Christ itself, and which include millions of people who might not die for him, but would definitely like to kill for him—as the post before yours once again confirms.

Are any of her family suburbanites?

I was thinking that, too, that the market might have already priced in sub-3% inflation, but an actual announcement to that effect might draw in the last of the retail holdouts and bring the market up to a new support level.

I think so, too, since when a contract gets traded, the acquiring team just assumes the contract unless other arrangements are made.

Well, if I don’t do it, who else will! 😅

Phillies, Angels, Yankees, Brewers, Cubs, Marlins could all probably use two months of help at third base for a playoff push. Maybe not the Mets so much, since they are abjectly collapsing. I wouldn’t be surprised to see him go back to the Cubs, since he’s a devil they know.

That’s true, and the market for Jeimer was very small—basically us, who didn’t want him around anymore, and Washington.

OK, I see. Since the incentives are definitely a part of his equation, though, wouldn’t that make the difference between the two examples much smaller in this real case?

If your third base options are struggling and you need a guy to push you over the top for this season, getting a guy on an expiring contract who’s arguably the best at that position and plays there only should not be a barrier to making a move.

No, you’re not crazy for saying that. To the degree that healthy pitching is always more valuable than hitting in the trade market, I would agree with this. Lorenzen and Jeimer together in the trade market would have fetched the most in the trade market. Maybe even together. Mets, Brewers, Yankees could all use both a good third baseman and another starter right now. That’s a competitive market right there.

Well, to be fair, you did preface this with “wild ass” … 😉

Exactly what I have implied before. I get your point about the money and its effect on the rest of the budget, but it also wouldn’t surprise me to learn that personal reasons were involved in the decision not to retain him—whether it was the personal distaste of the owner for the bad press Jeimer’s lack of performance generated, or the personal desire of Jeimer to get the hell out of this organization, or the personal distaste the other guys might have had for Jeimer as a teammate. I know nothing about any of that—I’m just speculating based on my calculation about the actual dollars involved, i.e., I have trouble believing the amount of money was the one nonstarter that was completely responsible for preventing the re-sign.

That’s because your hypothetical wife is a bitch.

Just so I have this straight, is CBT based only on base salary, and achieved incentives are not part of that? If Candelario is traded at the exact midpoint on a $7MM straight contract, that’s $3.5MM. Easy peasy. If he’s traded on his current contract and he hits the remaining three incentive benchmarks, that’s $2.5MM in base plus $600K in incentives he’ll paid, which makes $3.1MM. But does the latter example still count as only $2.5MM against the CBT, as in your example, because only the base counts against it?

I might be the only person here who thought that $7 million would not have been an overpay for Jeimer, because I was thinking of it in terms of paying him for the season he was projected to have coming up, which was more than one win by the lowest estimates, rather than paying him for the season he just had, for which he should have been paying us. I also may have been the only person who thought that the low end projections of slightly more than a single win was really low, that he would probably exceed that that at least half a win, and that even if not, the cost of being wrong would have been pretty minimal, and not close to being ruinous of our plans to rebuild the organization. IOW, I thought it would have been a low risk/high reward sign. But then, I see how other folks could look at his 2022 and think he was done done, too.

OK, I thought maybe you were sad at the idea of his going to the All-Star Game, which I couldn't figure out.

I was worried he'd get imaging showing a sprain and time off from gettign hit on the inside of the knee. My MCL got sprained last year when I got hit on the outside of my knee and it's been dodgy ever since. But they must think he's not showing any signs of ligament damage. Thank goodness for that. Bones can heal; some ligaments can't.

I don’t think I’m clear on your point, then. I thought you were talking about the return on trade based on what a team would have to pay the player for the remainder of the year.